| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064375A2 Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases |
| 06/22/2006 | WO2006064189A1 Oxadiazole derivatives as dgat inhibitors |
| 06/22/2006 | WO2006064044A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | WO2006013049A3 Benzyloxy derivatives as maob inhibitors |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135769 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 06/22/2006 | US20060135763 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; e.g. 10-(8-Methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenoxazine-3-carboxylic acid diethylamide |
| 06/22/2006 | US20060135593 N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/22/2006 | US20060135589 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors |
| 06/22/2006 | US20060135578 Five-membered heterocyclic compounds |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135530 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/22/2006 | US20060135523 2-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulator |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135515 Heterocyclic amides and their use treating thromboembolic diseases and tumors |
| 06/22/2006 | US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/22/2006 | US20060135398 Crystalline modification |
| 06/22/2006 | US20060134764 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 06/22/2006 | DE102004060984A1 New 4-heterocyclyl-benzamide derivatives, useful as antithrombotic agents for treating or preventing e.g. deep vein thrombosis or reocclusion after angioplasty, are inhibitors of factor Xa and other serine proteases |
| 06/22/2006 | CA2592353A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2591033A1 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | CA2590299A1 Piperazinyl-pyridine analogues |
| 06/22/2006 | CA2589678A1 Novel mch receptor antagonists |
| 06/22/2006 | CA2589501A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | CA2589363A1 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | CA2588909A1 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | CA2588162A1 Oxadiazole derivatives as dgat inhibitors |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1670793A1 Antibacterial agents |
| 06/21/2006 | EP1670792A1 Process for the preparation of chiral propionic acid derivatives |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1670790A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/21/2006 | EP1670786A1 Quinazoline derivatives |
| 06/21/2006 | EP1670781A1 Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof |
| 06/21/2006 | EP1670773A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 06/21/2006 | EP1670770A1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof |
| 06/21/2006 | EP1670768A1 Compounds and methods for treating dyslipidemia |
| 06/21/2006 | EP1670760A1 Organic compounds |
| 06/21/2006 | EP1670757A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 06/21/2006 | EP1670478A2 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase |
| 06/21/2006 | EP1670476A2 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 06/21/2006 | EP1670474A2 Cyclic pyrazinoylguanidine sodium channel blockers |
| 06/21/2006 | EP1670473A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 06/21/2006 | EP1670460A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 06/21/2006 | EP1670314A2 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 06/21/2006 | EP1501516B1 A process for the preparation of benazepril hydrochloride |
| 06/21/2006 | EP1301469B1 Preparation of 4-thioalkylbromobenzene derivatives |
| 06/21/2006 | EP1286985B1 Substituted pyridine herbicides |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | CN1791598A Benzimidazole-derivatives as factor Xa inhibitors |
| 06/21/2006 | CN1791596A Anti-cancer medicaments |
| 06/21/2006 | CN1791581A Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1791402A Ophthalmic compositions for treating ocular hypertension |
| 06/21/2006 | CN1789273A Soluble salt of azithromycin and its preparation process |
| 06/21/2006 | CN1789250A Optical antimer of a group of nitro imidazole derivatives, preparation method and uses thereof |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064207 Androgen receptor antagonists |
| 06/20/2006 | US7064202 Camptothecin intermediates and prodrugs and methods of preparation thereof |
| 06/20/2006 | US7064144 Imidazole derivatives as adenosine deaminase inhibitors |
| 06/20/2006 | US7064143 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., ethyl 4-hydroxy-1-methyl-1H-indole-2-carboxylate and N-methyl-N-phenethyl 4-hydroxy-1-methyl-1H-indole-2-carboxamide; used for treatment of Alzheimer's disease, anxiety or schizophrenia |
| 06/20/2006 | US7064135 Antihistamines; anticholesterol agents; cardiovascular disorders; antidiabetic agents; anticancer agents |
| 06/20/2006 | US7064131 Compounds and methods for inhibiting MRP1 |
| 06/20/2006 | US7064129 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life |
| 06/20/2006 | US7064124 nuclear factor (NF); inflammatory diseases, autoimmune diseases and viral diseases; 4-(3,4,5,6-tetramethoxy-2-methylbenzyl)-2-benzyloxybenzoic acid or 4-(5,6-dimethoxy-3-methyl-1,4-benzoquinon-2-yl)methyl-2-benzyloxybenzoic acid, for example |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/15/2006 | WO2006062982A2 Urea inhibitors of map kinases |
| 06/15/2006 | WO2006062478A1 Novel treatment of gastrointestinal disorders |
| 06/15/2006 | WO2006062224A1 Carboxamide derivative |
| 06/15/2006 | WO2006061493A1 Substituted indoles, compositions containing them, method for the production thereof and their use |
| 06/15/2006 | WO2006061379A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | WO2006061377A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | WO2006061376A1 Aryloxyethylamine derivatives with a combination of partial d0pamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/15/2006 | WO2006061116A1 Pyrazine dicarboxamides and the use thereof |
| 06/15/2006 | WO2006034822A8 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 06/15/2006 | WO2006026135A3 Substituted biaryl piperazinyl-pyridine analogues |
| 06/15/2006 | WO2006023778A3 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
| 06/15/2006 | WO2006002434A3 Novel indazole carboxamides and their use |
| 06/15/2006 | WO2005056535A8 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 06/15/2006 | US20060128965 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid |
| 06/15/2006 | US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists |
| 06/15/2006 | US20060128961 Process for the production of meso-substituted cyanine dyes |
| 06/15/2006 | US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors |
| 06/15/2006 | US20060128759 Substituted isoxazole derivatives and their use in pharmaceutics |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128722 Indoles useful in the treatment of androgen-receptor related diseases |
| 06/15/2006 | US20060128717 Therapeutic agents useful for treating pain |
| 06/15/2006 | US20060128712 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups |
| 06/15/2006 | US20060128706 Apoptosis promoters |